学术探索
学术期刊
新闻热点
数据分析
智能评审

IMPORTANCE OF GENETIC-FACTORS IN THE REGULATION OF DIAZEPAM METABOLISM - RELATIONSHIP TO S-MEPHENYTOIN, BUT NOT DEBRISOQUIN, HYDROXYLATION PHENOTYPE

被引：263
作者：
BERTILSSON, L
HENTHORN, TK
SANZ, E
TYBRING, G
SAWE, J
VILLEN, T
机构：
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1989年 / 45卷 / 04期
关键词：
D O I：
10.1038/clpt.1989.40
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：348 / 355
页数：8
相关论文
共 41 条
  • [1] ABERNETHY DR, 1983, J PHARMACOL EXP THER, V224, P508
  • [2] PHARMACOGENETIC STUDY WITH DIAZEPAM IN TWINS
    ALDA, M
    DVORAKOVA, M
    POSMUROVA, M
    BALIKOVA, M
    ZVOLSKY, P
    FILIP, V
    [J]. NEUROPSYCHOBIOLOGY, 1987, 17 (1-2) : 4 - 8
  • [3] BERLIN A, 1972, CLIN PHARMACOL THER, V13, P733
  • [4] PHARMACOKINETICS AND METABOLISM OF VARIOUS BENZODIAZEPINES USED AS HYPNOTICS
    BREIMER, DD
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 : S7 - S13
  • [5] PHARMACOKINETICS OF CLOSELY RELATED BENZODIAZEPINES
    CURRY, SH
    WHELPTON, R
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 : S15 - S21
  • [6] EFFECTS AND PLASMA-LEVELS OF N-DESMETHYLDIAZEPAM AFTER ORAL-ADMINISTRATION IN NORMAL VOLUNTEERS
    DASBERG, HH
    [J]. PSYCHOPHARMACOLOGIA, 1975, 43 (02): : 191 - 198
  • [7] DUTCHER JS, 1977, CLIN PHARMACOL THER, V22, P447
  • [8] POLYMORPHIC OXIDATION OF SPARTEINE AND DEBRISOQUINE - RELATED PHARMACOGENETIC ENTITIES
    EICHELBAUM, M
    BERTILSSON, L
    SAWE, J
    ZEKORN, C
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (02) : 184 - 186
  • [9] EICHELBAUM M, 1982, CLIN PHARMACOKINET, V7, P1, DOI 10.2165/00003088-198207010-00001
  • [10] A FAMILY AND POPULATION STUDY OF THE GENETIC-POLYMORPHISM OF DEBRISOQUINE OXIDATION IN A WHITE BRITISH-POPULATION
    EVANS, DAP
    MAHGOUB, A
    SLOAN, TP
    IDLE, JR
    SMITH, RL
    [J]. JOURNAL OF MEDICAL GENETICS, 1980, 17 (02) : 102 - 105
12345